NIH-Supported Study Links Sleep ECG Data to Future Cardiac Risk
NIH-supported study found that combining sleep-stage information with single-lead ECG recordings could help identify people at higher risk of future cardiovascular outcomes.
Cardiovascular Events | 12/10/2026 | By News Bureau
Newron Reviews FDA Feedback on Evenamide Clinical Hold in US
Newron Pharmaceuticals is reviewing FDA feedback on the clinical hold in US study centres for its Phase 3 ENIGMA-TRS 2 trial of evenamide following potential cardiac safety concerns.
Cardiovascular Events | 12/10/2026 | By News Bureau
US FDA Approves Wegovy by Novo Nordisk as first Oral GLP-1 for Weight Loss
Wegovy’s approval is supported by phase III OASIS 4 trial data showing a mean weight loss of 16.6 percent, with the oral GLP-1 indicated for long-term weight management and reduction of major adverse cardiovascular events, and Novo Nordisk planning a US launch in early January 2026.
Cardiovascular Events | 23/12/2025 | By News Bureau | 437
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy